These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 21708378

  • 1. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography.
    Manjunath V, Goren J, Fujimoto JG, Duker JS.
    Am J Ophthalmol; 2011 Oct; 152(4):663-8. PubMed ID: 21708378
    [Abstract] [Full Text] [Related]

  • 2. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T.
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [Abstract] [Full Text] [Related]

  • 3. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.
    Kang HM, Kwon HJ, Yi JH, Lee CS, Lee SC.
    Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050
    [Abstract] [Full Text] [Related]

  • 4. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study.
    Ting DS, Ng WY, Ng SR, Tan SP, Yeo IY, Mathur R, Chan CM, Tan AC, Tan GS, Wong TY, Cheung CM.
    Am J Ophthalmol; 2016 Apr; 164():128-36.e1. PubMed ID: 26743619
    [Abstract] [Full Text] [Related]

  • 5. Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up.
    Inan S, Baysal Z, Inan UU.
    Curr Eye Res; 2019 Aug; 44(8):908-915. PubMed ID: 30909756
    [Abstract] [Full Text] [Related]

  • 6. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
    Yamazaki T, Koizumi H, Yamagishi T, Kinoshita S.
    Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
    [Abstract] [Full Text] [Related]

  • 7. Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration.
    Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Kawasaki R, Sekiryu T, Okada AA, Iida T.
    Am J Ophthalmol; 2015 Apr; 159(4):627-33. PubMed ID: 25555799
    [Abstract] [Full Text] [Related]

  • 8. Analysis of short-term change in subfoveal choroidal thickness in eyes with age-related macular degeneration using optical coherence tomography.
    Fein JG, Branchini LA, Manjunath V, Regatieri CV, Fujimoto JG, Duker JS.
    Ophthalmic Surg Lasers Imaging Retina; 2014 Apr; 45(1):32-7. PubMed ID: 24392909
    [Abstract] [Full Text] [Related]

  • 9. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M, Boddu S, Chen CY, Jung JJ, Mrejen S, Gallego-Pinazo R, Freund KB.
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [Abstract] [Full Text] [Related]

  • 10. Choroidal Morphology and Vascular Analysis in Eyes With Neovascular Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography.
    Legocki AT, Adhi M, Weber ML, Duker JS.
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jul 01; 47(7):618-25. PubMed ID: 27434892
    [Abstract] [Full Text] [Related]

  • 11. Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial.
    Fan W, Abdelfattah NS, Uji A, Lei J, Ip M, Sadda SR, Wykoff CC, TREX-AMD Study Group.
    Graefes Arch Clin Exp Ophthalmol; 2018 Mar 01; 256(3):511-518. PubMed ID: 29374796
    [Abstract] [Full Text] [Related]

  • 12. Effect of anti-VEGF treatment on choroidal thickness over time in patients with neovascular age-related macular degeneration.
    McDonnell EC, Heussen FM, Ruiz-Garcia H, Ouyang Y, Narala R, Walsh AC, Sadda SR.
    Eur J Ophthalmol; 2014 Mar 01; 24(6):897-903. PubMed ID: 25044137
    [Abstract] [Full Text] [Related]

  • 13. CHOROIDAL IMAGING BIOMARKERS TO PREDICT HIGHLY RESPONSIVE AND RESISTANT CASES TREATED WITH STANDARDIZED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR REGIMEN IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Jhingan M, Cavichini M, Amador M, Dans K, Bartsch DU, Cheng L, Chhablani J, Freeman WR.
    Retina; 2021 Oct 01; 41(10):2115-2121. PubMed ID: 34543243
    [Abstract] [Full Text] [Related]

  • 14. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ, Comparison of Age-related Macular Degeneration Treatments Trials Research Group.
    Ophthalmology; 2016 Apr 01; 123(4):865-75. PubMed ID: 26783095
    [Abstract] [Full Text] [Related]

  • 15. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
    Shin JY, Kwon KY, Byeon SH.
    Acta Ophthalmol; 2015 Sep 01; 93(6):524-32. PubMed ID: 25581639
    [Abstract] [Full Text] [Related]

  • 16. Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab.
    Montero JA, Ruiz-Moreno JM, Sanchis-Merino E, Perez-Martin S.
    Retina; 2013 Mar 01; 33(3):508-12. PubMed ID: 23099497
    [Abstract] [Full Text] [Related]

  • 17. Retinal and choroidal thickness changes after single anti-VEGF injection in neovascular age-related macular degeneration: ranibizumab vs bevacizumab.
    Sizmaz S, Kucukerdonmez C, Kal A, Pinarci EY, Canan H, Yilmaz G.
    Eur J Ophthalmol; 2014 Mar 01; 24(6):904-10. PubMed ID: 24803153
    [Abstract] [Full Text] [Related]

  • 18. Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration.
    Kim JH, Kim JR, Kang SW, Kim SJ, Ha HS.
    Am J Ophthalmol; 2013 Apr 01; 155(4):743-9, 749.e1-2. PubMed ID: 23317655
    [Abstract] [Full Text] [Related]

  • 19. Relationship of central choroidal thickness with age-related macular degeneration status.
    Yiu G, Chiu SJ, Petrou PA, Stinnett S, Sarin N, Farsiu S, Chew EY, Wong WT, Toth CA.
    Am J Ophthalmol; 2015 Apr 01; 159(4):617-26. PubMed ID: 25526948
    [Abstract] [Full Text] [Related]

  • 20. Macular choroidal thickness and volume of eyes with reticular pseudodrusen using swept-source optical coherence tomography.
    Ueda-Arakawa N, Ooto S, Ellabban AA, Takahashi A, Oishi A, Tamura H, Yamashiro K, Tsujikawa A, Yoshimura N.
    Am J Ophthalmol; 2014 May 01; 157(5):994-1004. PubMed ID: 24491418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.